Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting.
about
Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension.Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study.Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% - an observational switch study.
P2860
Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Bimatoprost 0.01 % for previou ...... n the Korean clinical setting.
@en
Bimatoprost 0.01 % for previou ...... n the Korean clinical setting.
@nl
type
label
Bimatoprost 0.01 % for previou ...... n the Korean clinical setting.
@en
Bimatoprost 0.01 % for previou ...... n the Korean clinical setting.
@nl
prefLabel
Bimatoprost 0.01 % for previou ...... n the Korean clinical setting.
@en
Bimatoprost 0.01 % for previou ...... n the Korean clinical setting.
@nl
P2093
P2860
P1476
Bimatoprost 0.01 % for previou ...... n the Korean clinical setting.
@en
P2093
Chan Yun Kim
Ki Ho Park
Michael Scott Kook
Susan Simonyi
Yong Ho Sohn
P2860
P2888
P304
P356
10.1007/S10384-015-0392-2
P577
2015-07-23T00:00:00Z